Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Mustang Bio Inc (MBIO)
Mustang Bio Inc (MBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mustang Bio Inc 377 PLANTATION STREET WORCESTER MA 01605 USA

www.mustangbio.com P: 781-652-4500

Description:

Mustang Bio, Inc. a subsidiary of Fortress Biotech, Inc., is a clinical'stage biopharmaceutical company. It focused on the development and commercialization of novel cancer immunotherapy products designed to leverage the patient's own immune system to eliminate cancer cells. Mustang Bio, Inc. is based in New York, United States.

Key Statistics

Overview:

Market Capitalization, $K 11,522
Enterprise Value, $K -36,699
Shares Outstanding, K 9,217
Annual Sales, $ 0 K
Annual Net Income, $ -77,530 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,060 K
EBIT, $ -59,950 K
EBITDA, $ -56,450 K
60-Month Beta 1.64
% of Insider Shareholders 2.10%
% of Institutional Shareholders 7.78%
Float, K 9,024
% Float 97.90%
Short Volume Ratio 0.45

Growth:

1-Year Return -85.43%
3-Year Return -97.64%
5-Year Return -97.92%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.23 on 11/14/23
Latest Earnings Date 04/03/24
Earnings Per Share ttm -7.99
EPS Growth vs. Prev Qtr 38.50%
EPS Growth vs. Prev Year 54.42%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 04/04/23

MBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -267.01%
Return-on-Assets % -116.13%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.67
Book Value/Share 0.48
Interest Coverage -22.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar